Literature DB >> 29536391

New insight into the management of IgA nephropathy.

Yonghua Zou1, Min Yang2, Xin Du3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29536391     DOI： 10.1007/s10157-018-1555-5

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN： 1342-1751            Impact factor:   2.801


× No keyword cloud information.
  4 in total

1.  Effect of corticosteroid therapy on low-molecular weight protein markers of kidney function.

Authors:  Arend Bökenkamp; Cèleste A R C Laarman; Katja I Braam; Joanna A E van Wijk; Wijnanda A Kors; Marijke Kool; Janneke de Valk; Anna A Bouman; Marieke D Spreeuwenberg; Birgit Stoffel-Wagner
Journal:  Clin Chem       Date:  2007-12       Impact factor: 8.327

2.  Performance of the creatinine and cystatin C-based equations for estimation of GFR in Chinese patients with chronic kidney disease.

Authors:  Min Yang; Guang Xu; Lilu Ling; Jianying Niu; Tong Lu; Xin Du; Yong Gu
Journal:  Clin Exp Nephrol       Date:  2016-04-28       Impact factor: 2.801

3.  Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.

Authors:  Thomas Rauen; Frank Eitner; Christina Fitzner; Claudia Sommerer; Martin Zeier; Britta Otte; Ulf Panzer; Harm Peters; Urs Benck; Peter R Mertens; Uwe Kuhlmann; Oliver Witzke; Oliver Gross; Volker Vielhauer; Johannes F E Mann; Ralf-Dieter Hilgers; Jürgen Floege
Journal:  N Engl J Med       Date:  2015-12-03       Impact factor: 91.245

4.  Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.

Authors:  Jicheng Lv; Hong Zhang; Muh Geot Wong; Meg J Jardine; Michelle Hladunewich; Vivek Jha; Helen Monaghan; Minghui Zhao; Sean Barbour; Heather Reich; Daniel Cattran; Richard Glassock; Adeera Levin; David Wheeler; Mark Woodward; Laurent Billot; Tak Mao Chan; Zhi-Hong Liu; David W Johnson; Alan Cass; John Feehally; Jürgen Floege; Giuseppe Remuzzi; Yangfeng Wu; Rajiv Agarwal; Hai-Yan Wang; Vlado Perkovic
Journal:  JAMA       Date:  2017-08-01       Impact factor: 56.272
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.